LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Clinical trials for LEUKEMIA, MYELOMONOCYTIC, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOMONOCYTIC, CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOMONOCYTIC, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug dasatinib shows promise for rare blood cancers
Disease control CompletedThis study tested the drug dasatinib in 68 adults with several blood and bone marrow disorders, including certain leukemias, myelofibrosis, and mastocytosis. The goal was to see if dasatinib could help control these diseases and to check its safety. Results focused on how many pa…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:00 UTC
-
New combo therapy aims to delay progression in blood cancers
Disease control CompletedThis study tested whether adding pevonedistat to the standard drug azacitidine helps people with certain blood cancers live longer without their disease getting worse. It included 454 adults with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or low-blast…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 17, 2026 03:59 UTC